3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.
BACKGROUND: Isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine metabolism caused by mutations in MCCC1 or MCCC2 encoding the α and β subunit of MCC, respectively. The phenotype is highly variable ranging from acute neonatal onset with fatal outco...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1826295955454951424 |
|---|---|
| author | Grünert, S Stucki, M Morscher, R Suormala, T Bürer, C Burda, P Christensen, E Ficicioglu, C Herwig, J Kölker, S Möslinger, D Pasquini, E Santer, R Schwab, K Wilcken, B Fowler, B Yue, W Baumgartner, MR |
| author_facet | Grünert, S Stucki, M Morscher, R Suormala, T Bürer, C Burda, P Christensen, E Ficicioglu, C Herwig, J Kölker, S Möslinger, D Pasquini, E Santer, R Schwab, K Wilcken, B Fowler, B Yue, W Baumgartner, MR |
| author_sort | Grünert, S |
| collection | OXFORD |
| description | BACKGROUND: Isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine metabolism caused by mutations in MCCC1 or MCCC2 encoding the α and β subunit of MCC, respectively. The phenotype is highly variable ranging from acute neonatal onset with fatal outcome to asymptomatic adults. METHODS: We report clinical, biochemical, enzymatic and mutation data of 88 MCC deficient individuals, 53 identified by newborn screening, 26 diagnosed due to clinical symptoms or positive family history and 9 mothers, identified following the positive newborn screening result of their baby. RESULTS: Fifty-seven percent of patients were asymptomatic while 43% showed clinical symptoms, many of which were probably not related to MCC deficiency but due to ascertainment bias. However, 12 patients (5 of 53 identified by newborn screening) presented with acute metabolic decompensations. We identified 15 novel MCCC1 and 16 novel MCCC2 mutant alleles. Additionally, we report expression studies on 3 MCCC1 and 8 MCCC2 mutations and show an overview of all 132 MCCC1 and MCCC2 variants known to date. CONCLUSIONS: Our data confirm that MCC deficiency, despite low penetrance, may lead to a severe clinical phenotype resembling classical organic acidurias. However, neither the genotype nor the biochemical phenotype is helpful in predicting the clinical course. |
| first_indexed | 2024-03-07T04:08:55Z |
| format | Journal article |
| id | oxford-uuid:c729bd90-d457-434f-9156-cf7a4d0c617c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:08:55Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:c729bd90-d457-434f-9156-cf7a4d0c617c2022-03-27T06:43:09Z3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c729bd90-d457-434f-9156-cf7a4d0c617cEnglishSymplectic Elements at Oxford2012Grünert, SStucki, MMorscher, RSuormala, TBürer, CBurda, PChristensen, EFicicioglu, CHerwig, JKölker, SMöslinger, DPasquini, ESanter, RSchwab, KWilcken, BFowler, BYue, WBaumgartner, MRBACKGROUND: Isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine metabolism caused by mutations in MCCC1 or MCCC2 encoding the α and β subunit of MCC, respectively. The phenotype is highly variable ranging from acute neonatal onset with fatal outcome to asymptomatic adults. METHODS: We report clinical, biochemical, enzymatic and mutation data of 88 MCC deficient individuals, 53 identified by newborn screening, 26 diagnosed due to clinical symptoms or positive family history and 9 mothers, identified following the positive newborn screening result of their baby. RESULTS: Fifty-seven percent of patients were asymptomatic while 43% showed clinical symptoms, many of which were probably not related to MCC deficiency but due to ascertainment bias. However, 12 patients (5 of 53 identified by newborn screening) presented with acute metabolic decompensations. We identified 15 novel MCCC1 and 16 novel MCCC2 mutant alleles. Additionally, we report expression studies on 3 MCCC1 and 8 MCCC2 mutations and show an overview of all 132 MCCC1 and MCCC2 variants known to date. CONCLUSIONS: Our data confirm that MCC deficiency, despite low penetrance, may lead to a severe clinical phenotype resembling classical organic acidurias. However, neither the genotype nor the biochemical phenotype is helpful in predicting the clinical course. |
| spellingShingle | Grünert, S Stucki, M Morscher, R Suormala, T Bürer, C Burda, P Christensen, E Ficicioglu, C Herwig, J Kölker, S Möslinger, D Pasquini, E Santer, R Schwab, K Wilcken, B Fowler, B Yue, W Baumgartner, MR 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. |
| title | 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. |
| title_full | 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. |
| title_fullStr | 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. |
| title_full_unstemmed | 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. |
| title_short | 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. |
| title_sort | 3 methylcrotonyl coa carboxylase deficiency clinical biochemical enzymatic and molecular studies in 88 individuals |
| work_keys_str_mv | AT grunerts 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT stuckim 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT morscherr 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT suormalat 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT burerc 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT burdap 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT christensene 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT ficiciogluc 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT herwigj 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT kolkers 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT moslingerd 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT pasquinie 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT santerr 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT schwabk 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT wilckenb 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT fowlerb 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT yuew 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals AT baumgartnermr 3methylcrotonylcoacarboxylasedeficiencyclinicalbiochemicalenzymaticandmolecularstudiesin88individuals |